Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
06/06/1996 | CA2205950A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
06/06/1996 | CA2205800A1 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
06/06/1996 | CA2205799A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
06/06/1996 | CA2205577A1 Hindered n-oxide esters of rapamycin and their use as medicaments |
06/05/1996 | EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands |
06/05/1996 | EP0714903A1 New carbohydrate conjugates as cell adhesion inhibitors |
06/05/1996 | EP0714895A1 Pyrrole derivatives |
06/05/1996 | EP0714449A1 Oligonucleotide modulation of protein kinase c |
06/05/1996 | EP0714408A1 Tryptase inhibitor |
06/05/1996 | EP0714404A1 Anti-inflammatory peptides |
06/05/1996 | EP0714397A1 Phenethylamine compounds |
06/05/1996 | EP0714386A1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations |
06/05/1996 | EP0714294A1 Pharmaceutical compositions comprising metal complexes |
06/05/1996 | EP0714293A1 3-cyano-3-(3,4-disubstituted)phenylcyclohexyl-1-carboxylates |
06/05/1996 | EP0714291A1 Lupane triterpenoid derivatives |
06/05/1996 | CN1124027A Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
06/05/1996 | CN1124026A Thioindole pyperidinyl derivatives used as antalgics |
06/05/1996 | CN1123686A Spraying agent for stopping pains |
06/05/1996 | CN1031940C Process for preparing substituted pyrrole compounds |
06/04/1996 | CA2019863C Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives |
06/02/1996 | CA2163490A1 Pyrrole derivatives |
05/30/1996 | WO1996016083A1 Peptides endowed with antiinflammatory activity |
05/30/1996 | WO1996016075A1 Antibiotic cryptdin peptides and methods of their use |
05/30/1996 | WO1996016041A1 Heteroaryl-substituted deoxy glycero-phosphoethanolamines |
05/30/1996 | WO1996016027A1 Matrix metalloprotease inhibitors |
05/30/1996 | WO1996015810A1 Monofunctional and/or polyfunctional polylysine conjugates |
05/29/1996 | EP0713698A2 Medical use of atypical beta-adrenoceptor agonists |
05/29/1996 | EP0713697A1 Analgesic anti-inflammatory adhesive preparations |
05/29/1996 | EP0713653A1 Fortified fruit juice |
05/29/1996 | EP0713495A1 Methods of enhancing bioactivity of chemokines |
05/29/1996 | EP0713483A1 Amidine derivatives with nitric oxide synthetase activities |
05/29/1996 | EP0713396A1 Medical use of stem bromelain protease |
05/29/1996 | EP0713386A1 Spray formulation having a cooling effect |
05/29/1996 | EP0506778B1 Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation |
05/29/1996 | EP0506658B1 Compositions and method for treating painful, inflammatory or allergic disorders |
05/29/1996 | EP0469065B1 Recombinant antibody-toxin fusion protein |
05/28/1996 | US5521315 Olefin substituted long chain compounds |
05/28/1996 | US5521220 Treating inflammatory and central nervous system disorders |
05/28/1996 | US5521213 Nonsteroid antiinflammatory agents |
05/28/1996 | US5521194 Antiproliferative agent for restenosis treatment |
05/28/1996 | US5521185 Methods for inhibiting graft rejection and IL-1 production |
05/28/1996 | US5521156 Cyclic neurokinin A antagonists |
05/28/1996 | CA2041330C Percutaneously absorbable eperisone or tolperisone preparation |
05/28/1996 | CA1338352C 2-substituted quinolines |
05/24/1996 | CA2163466A1 Fortified fruit juices |
05/23/1996 | WO1996015153A1 Human antibodies to t-cell receptor peptides and methods for their preparation |
05/23/1996 | WO1996015126A1 Furan derivatives for inhibiting pneumocystis carinii pneumonia, giardia lamblia and cryptosporidium parvum |
05/23/1996 | WO1996015123A1 Pyridine modulators of acetylcholine receptors |
05/23/1996 | WO1996015106A1 Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors |
05/23/1996 | WO1996014876A1 Yeast-based delivery vehicles |
05/23/1996 | WO1996014844A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase |
05/23/1996 | CA2205138A1 Human antibodies to t-cell receptor peptides and methods for their preparation |
05/23/1996 | CA2204898A1 Methods of inhibiting pneumocystis carini pneumonia, giardia lamblia, and cryptosporidum parvum and compounds useful therefor |
05/22/1996 | EP0712631A2 Cyclosporin containing multiple emulsions |
05/22/1996 | EP0712390A1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors |
05/22/1996 | EP0712389A1 Therapeutic compound - fatty acid conjugates |
05/22/1996 | CN1123005A Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid |
05/22/1996 | CN1031826C Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories |
05/21/1996 | US5519163 Inhibitors of phosphoinositide-specific phospholipase C |
05/21/1996 | US5519134 Pyrrolidine-containing monomers and oligomers |
05/21/1996 | US5519036 Cyclic derivatives pharmaceutical compositions containing these compounds and processes for preparing them |
05/21/1996 | US5519022 α, α dialkylbenzyl derivatives |
05/21/1996 | US5519008 Antiinflammatory agents |
05/21/1996 | US5518999 Method for treating Kaposi's sarcoma and blocking or inhibiting vascular permeability |
05/21/1996 | US5518911 Human PAK65 |
05/21/1996 | US5518738 Nanoparticulate nsaid compositions |
05/18/1996 | CA2160841A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
05/17/1996 | WO1996014339A1 Antibodies |
05/17/1996 | WO1996014329A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides |
05/17/1996 | WO1996014328A1 Tumor necrosis factor-gamma |
05/17/1996 | WO1996014302A1 Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects |
05/17/1996 | WO1996004266A3 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects |
05/17/1996 | CA2307311A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides |
05/15/1996 | EP0711550A1 Cyclosporin-containing soft capsule compositions |
05/15/1996 | EP0711282A1 Compounds as pde iv and tnf inhibitors |
05/15/1996 | EP0711281A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
05/15/1996 | EP0711280A1 Perhydroisoindole derivatives as p substance antagonists |
05/15/1996 | EP0711159A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton |
05/15/1996 | DE19509279C1 Dermatomyositis-spezifisches Autoantigen Dermatomyositis-specific autoantigen |
05/15/1996 | CN1122600A Second messenger cell signaling inhibitors |
05/15/1996 | CN1122337A Stable crystalline (6S)-and (6R)-tetrahydrofolic acid |
05/09/1996 | WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
05/09/1996 | WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances |
05/09/1996 | WO1996013517A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
05/09/1996 | WO1996013500A1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
05/09/1996 | WO1996013491A1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
05/09/1996 | WO1996013485A1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists |
05/09/1996 | WO1996013484A1 Azetidinone derivatives for the treatment of atherosclerosis |
05/09/1996 | WO1996013483A1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors |
05/09/1996 | WO1996013290A1 Device for aerosolized delivery of peptide drugs |
05/09/1996 | WO1996013273A1 Pharmaceutical compositions |
05/09/1996 | WO1996013266A1 Boronic ester and acid compounds, synthesis and uses |
05/09/1996 | CA2203827A1 Novel family of protease inhibitors, and other biologic active substances |
05/09/1996 | CA2203659A1 Pyridopyrimidones, quinolines and fused n-heterocycles as bradykinin antagonists |
05/09/1996 | CA2203257A1 Device for aerosolized delivery of peptide drugs |
05/09/1996 | CA2200462A1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors |
05/09/1996 | CA2173874A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
05/08/1996 | EP0710251A1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
05/08/1996 | EP0710241A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them |
05/08/1996 | EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |